Cases
Experience: Joint Venture
Technology Collaboration: Assisted BP in creation of multiple joint ventures in China
Assisted Castrol in collaborations with auto makers
service providers in China
Assisted in a cross-border technology transfer transaction for multiple China-based pharmaceutical company as licensee
Assisted several US companies in managing its IP portfolio
IP enforcement in China
M&A: Advised Tuscan Holding Corp in its de-SPAC transaction with Microvast
Advised SJL Partners, KCC
Wonik in connection with the matters relating to their US$3.1 billion acquisition of MPM Holdings (Momentive), a leading global specialty chemicals
materials company based in Waterford, NY, h
ling post-closing corporate restructuring
business integration (including in mainl
China, Taiwan, Japan
Singapore)
Advised on post-closing corporate restructuring (including in Japan, mainl
China, Hong Kong) for Quaker Houghton, a global supplier of industrial process fluids
Represented Medtronic is divesting its subsidiary Beijing Libeier Bio-engineering Institute, Ltd. to AK Medical International Limited, a HK listed company at the price of US$ 40.2 million
Advised Volvo CE in its divestiture of NHL
Assisted a US investor in acquisition of another US company's agrichemical business,
associated asset transfer in China
Assisted Volvo CE in acquisition of Terex, a UK-based company's off-road hauler business, conducting due diligence on the target's Chinese business
assisted in CSRC filing
VC Investment: Advised a RMB fund on its USD10 million preferred stock investment in a US startup specialized in the reagents
services of next generation sequencing
Advised a USD fund on its RMB90 million preferred stock investment in a China-based manufacturer of orthopedics products
Advised a USD fund on its USD15 million preferred stock investment in a China-based provider of pharmacy benefit manager services
Advised a RMB fund on its USD10 million preferred stock investment in a China-based intraocular lens manufacturer
Assisted a USD fund in its USD25 million preferred stock investment in a China-based traditional Chinese medicine service provider
Advised a Chinese fund on a 6 million preferred stock investment in a medical device manufacturer in China
Advised a US fund on a 90 million RMB preferred stock investment in a hospital management company in China
Advised a US fund on a 20 million USD preferred stock investment in a vaccine producer in China
Advised a Korean fund on a 5 million USD convertible bond investment in a chain hotel company in China